Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection
Reported by Jules Levin
EASL 2018 Paris France
Christine Wooddell, Rui Zhu, Holly Hamilton, Qili Chu, Heather Sternard, Joshua Schumacher, Thomas Schluep, Mark Seefeld, Zhen Li, Bruce Given
Arrowhead Pharmaceuticals, Madison, WI, United States
